STEPHANIE ALLOCCA: Open Payments
NPI 1700284981 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 31 payments from 8 companies in 2025. Trend: 2023 $425 · 2024 $298 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 13 | $162 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $72 |
| Organon LLC | 3 | $41 |
| MILLICENT US INC | 2 | $33 |
| Sage Therapeutics, LLC | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Boston Scientific Corporation | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: SLYND, FEMLYV, ZURZUVAE, NEXPLANON, GARDASIL 9, WATCHMAN FLX, Qelbree.
Industry payments across NJ — which companies pay providers there.
